Seeking Alpha

AstraZeneca plc (AZN)

()

News & PR
Market Currents

Buzz
Twitter: AZN

Business Intelligence
Transcripts
Events
Key Developments

Instablog posts on AZN

The Top 4 Healthcare Dividend Stocks – Covered Call Trades by Double Dividend Stocks
Starting with picks from the Healthcare section of our High Dividend Stocks by Sector tables, we ran a screen for Healthcare dividend paying stocks with the highest yields from a combination of the highest dividend yield and covered call options. We came up with a Dividend & Covered Call... More »
November 5, 2009 • AZN, GSK, LLY
Kendle International Healthcare by Michael Michaud
The Market Last Week and AheadFirst, the most important date report in the financial universe, the US Non-Farm Payroll Report is Friday. Last Friday authorities seized nine US banks. If people continue to carry trade the dollar and if they start to unwind those trades more traders and investors... More »
November 2, 2009 • KNDL, CVD, PRXL
ETF for the FLU by Don Dion
As many of us were recovering from the flu, AstraZeneca reported strong earnings growth in the third quarter. The company's nasal spray vaccine is in great demand as many people like me avoid needles. Investors looking for diversified exposure to the major companies that are selling high demand... More »
October 30, 2009 • AZN, IXJ, NVS
Incyte – Life After Debt (Part II) by Ohad Hammer
For part I click here On top its JAK programs, Incyte has been developing two additional programs it intends to out-license. The first program is INCB13739 for diabetes, which already reached clinical proof of concept and could be licensed imminently. The second program, INCB7839 for breast... More »
October 18, 2009 • INCY, AZN, MRK
A Great FREE Way To Start Learning About European Companies and Accounting Standards by The Manual of Ideas
There is no better way of learning a new language than by going to the country where it's spoken. Similarly, if you are looking to expand your horizons and learn about European investment opportunities, there is no better way than by tackling as many European company annual reports as you can... More »
October 14, 2009 • AZN, DB, RDS.A
H1N1 -- How to buy into the fear by Jim Van Meerten
The whole world seems to be fixated on the economy and the H1N1 Swine Flu. News reports today that the first shipments of the nasal version of the vaccine, manufactured by MedImmune a unit of AstraZeneca, will begin today pushed me to find out if there might be an investing play in this fear.... More »
October 6, 2009 • GSK, SNY, NVS
Keep and eye on BMY and AZN for their diabetes drug Dapagliflozin. by Jack Haddad
In a six-month trial, the drug was able to lower HbA1c levels -- a measure of long-term glucose levels -- better than placebo.Dapagliflozin is in a new class of diabetes medications that inhibits the kidneys from moving glucose back into the bloodstream, and thereby lowers the glucose levels in... More »
October 5, 2009 • AZN, MRK
Spectrum Pharmaceuticals: Post Zevalin Approval Sales Should Ramp Up by Justin M. Hall
As many, who have followed and/or invested in Spectrum Pharmaceuticals (SPPI), know Zevalin® was finally (and thankfully) approved last Friday, September 4 by the FDA for first-line consolidation use in patients with non-Hodgkins lymphoma (NHL). PRELIMINARY FACTSZevalin is the first of... More »
September 11, 2009 • BMY, PFE, OSIP
Three Recent Biotechnology Activist Wins by Carl Icahn by Michael Becker
Although a controversial topic, activist hedge funds and private equity firms typically use a small equity stake in an underperforming company to put public pressure on its management and board of directors with the goal of increasing stakeholder value through cost cutting, changes in corporate... More »
August 30, 2009 • ALKS, AMLN, AZN
AstraZeneca - Dividend Investment Analysis by Capital Preserve
AstraZeneca (AZN) like many foreign stocks gets little attention from investors who focus on, and write about dividend stocks. This aversion seems to stem from a couple of primary sources. First, foreign dividend payers do not typically pay dividends on a quarterly basis and the... More »
July 30, 2009 • AZN

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

AstraZeneca plc (AZN)

Instablog posts on AZN

The Top 4 Healthcare Dividend Stocks – Covered Call Trades by Double Dividend Stocks

Kendle International Healthcare by Michael Michaud

ETF for the FLU by Don Dion

Incyte – Life After Debt (Part II) by Ohad Hammer

A Great FREE Way To Start Learning About European Companies and Accounting Standards by The Manual of Ideas

H1N1 -- How to buy into the fear by Jim Van Meerten

Keep and eye on BMY and AZN for their diabetes drug Dapagliflozin. by Jack Haddad

Spectrum Pharmaceuticals: Post Zevalin Approval Sales Should Ramp Up by Justin M. Hall

Three Recent Biotechnology Activist Wins by Carl Icahn by Michael Becker

AstraZeneca - Dividend Investment Analysis by Capital Preserve

The Seeking Alpha 100

Fastest Climbers

Top Commenters

Top Instabloggers

Top StockTalkers